In The News Posted January 31, 2019 Share Posted January 31, 2019 TOKYO and LONDON, January 31, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565), announces its wholly-owned Japanese subsidiary Sosei Co., Ltd. ("the Business"), will launch ORAVI® Mucoadhesive Tablets 50mg in Japan on 4 February 2019. ORAVI® is a novel once-daily... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.